Xarelto Lawyer

Published on October 7, 2014 by Sandy Liebhard

Text-Size:A A A+

Calling a Xarelto lawyer doesn’t have to mean paying tons of extraneous legal fees and other expenses rumored to be associated with filing a case. When you work with attorneys at Bernstein Liebhard LLP, which operates on a contingency-fee basis, you only pay the Firm if a recovery is made on your behalf. Relieved? Now there’s nothing stopping you from filing a case over the new-generation blood thinner that may have caused you or a loved one to suffer life-threatening episodes of internal bleeding, or another injury that may entitle you to compensation for damages incurred by your unfortunate situation.

Xarelto attorneys at Bernstein Liebhard LLP are readily available to answer any legal questions you have regarding the process of filing a Xarelto Lawsuit that alleges cerebral or gastrointestinal hemorrhaging, strokes, or another injury that may be life-threatening. Call our Firm today at .

Xarelto Lawyers Keep Pulse on Blood Thinner Complaints

Since it was discovered that the U.S. Food and Drug Administration (FDA) logged more than 2,000 complaints of Xarelto side effects in 2012, plaintiffs’ law firms throughout the U.S. have been actively monitoring the nationwide probe of its safety. In findings published that year by the Institute for Safe Medicine Practices (ISMP), 151 deaths following use of Xarelto were also noted in FDA-filed adverse event reports.

Xarelto internal bleeding episodes were shown to be fatal for 7.2 percent of elderly patients, compared to those being treated with warfarin, a similar medication that has been on the market for years. Warfarin bleeding injuries were fatal in 6.5 percent of users, the ISMP found.

Xarelto lawyers are eager to speak with anyone who suffered the following injuries:

  • Internal bleeding (intracranial hemorrhage, spinal and epidural hematoma, gastrointestinal hemorrhage, adrenal bleeding)
  • Stroke
  • Pulmonary embolism (PE)
  • Deep vein thrombosis (DVT)

Xarelto LawyerXarelto belongs to a class of new-generation blood thinners known as direct-thrombin inhibitors. Approved in 2011 by the FDA, the drug was originally just cleared in patients undergoing knee or hip replacement surgery who may be at risk for serious blood clots, Deep Vein Thrombosis (DVT) and pulmonary embolism (PE). Since then, Xarelto has received clearance for the prevention of strokes in atrial fibrillation patients, and to treat pulmonary embolism (PE) and deep vein thrombosis (DVT).

In 2013, Xarelto’s manufacturer garnered $1.3 billion in sales of the medication.

Call a Xarelto Lawyer Today

Call our Firm today to speak with a Xarelto lawyer who can walk you through the legal process of filing a claim, and can educate you about your legal rights. Contact us now at .

Web Analytics